Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,517 | -20,331 | -66,995 | -42,381 | -17,579 |
| Depreciation Amortization | 674 | 340 | 836 | 619 | 409 |
| Accounts receivable | -5,777 | -2,753 | -3,860 | -3,946 | N/A |
| Accounts payable and accrued liabilities | -1,330 | 52 | 2,201 | 1,623 | 1,502 |
| Other Working Capital | -4,902 | -2,511 | 9,859 | 4,992 | 5,273 |
| Other Operating Activity | 12,547 | 5,256 | 19,382 | 15,023 | 1,136 |
| Operating Cash Flow | $-36,305 | $-19,947 | $-38,577 | $-24,070 | $-9,259 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | N/A | -362 | -135 | -70 |
| Investing Cash Flow | $-11 | $N/A | $-362 | $-135 | $-70 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 44,105 | 44,105 | N/A |
| Debt Repayment | -1,455 | -665 | -23 | N/A | N/A |
| Common Stock Issued | 154 | 4 | 30,307 | 30,308 | 30,308 |
| Other Financing Activity | 0 | 0 | -176 | -173 | -112 |
| Financing Cash Flow | $-1,301 | $-661 | $74,213 | $74,240 | $30,196 |
| Beginning Cash Position | 69,547 | 69,547 | 34,273 | 34,273 | 34,273 |
| End Cash Position | 31,930 | 48,939 | 69,547 | 84,308 | 55,140 |
| Net Cash Flow | $-37,617 | $-20,608 | $35,274 | $50,035 | $20,867 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,305 | -19,947 | -38,577 | -24,070 | -9,259 |
| Capital Expenditure | -11 | N/A | -362 | -135 | -70 |
| Free Cash Flow | -36,316 | -19,947 | -38,939 | -24,205 | -9,329 |